How Well Relpax Works

Introduction to Relpax Efficacy

Relpax has been extensively studied. It has been approved by the Food and Drug Administration (FDA) for its use in the United States. Like all prescription medicines, Relpax had to be evaluated for how well it works on migraines in relation to the number and types of side effects. Only you and your doctor can decide together if taking the medicine provides enough benefit to outweigh any potential risks.

Studies Show that Relpax Works to Treat a Migraine in Progress

Efficacy of Relpax –

How well Relpax works for migraines was evaluated in a large number of patients in seven adult studies Some of the studies used a dose of 40 mg and several also evaluated 80 mg dose and 20 mg doses.

In all studies, patients treated a moderate to severe headache. How much the headache pain was reduced was assessed up to 2 hours after taking the medicine. Patient response was assessed for up to 24 hours after taking the medicine.

In the adult studies, significantly more patients experienced pain relief 2 hours after taking Relpax tablets at all doses compared to those who received placebo (a sugar pill that contains no medicine). The medicine also relieved feelings of nausea, and sensitivity to light and sound.

Deciding if Relpax is Right for You

Relpax has been used effectively by millions of consumers in the United States. Only a doctor can decide if Relpax is right for you, but you should understand the potential benefits and risks of taking this medicine.

Tell your doctor about your symptoms. Your doctor will decide if you have migraine. Use Relpax only for a migraine attack — it should not be used to treat headaches that might be caused by other, more serious conditions. If you are taking Relpax and have any concerns, be sure to speak with your doctor. Never stop taking any medicine without your doctor’s advice.

Written & reviewed by: Lisa Erwin R.Ph. CGP | Last review date: Dec 2010. Click the References Link below for a complete list of references.

Written & reviewed by: Lisa Erwin R.Ph. CGP | Last review date: Dec 2010.
View References